Cannara Biotech Inc. (8CB0)
XMUN 
Summary
8CB0 Chart
Cannara Biotech Inc. (8CB0) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Cannara Biotech Inc. ever had a stock split?
Cannara Biotech Inc. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Zohar Krivorot CEO | XMUN Exchange | - ISIN |
| CA Country | 461 Employees | - Last Dividend | 13 Feb 2023 Last Split | - IPO Date |
Overview
Cannara Biotech Inc., founded in 2017, is a Canadian company situated in Saint-Laurent, Canada, that delves into the cannabis industry with a focus on indoor cultivation, processing, and the sale of cannabis and cannabis-derivated products. Its operations are not limited to cannabis, as it extends its product range to include hemp-based CBD products, catering to a diverse market. In addition to its primary business lines, Cannara Biotech engages in real estate operations, showcasing a broad operational scope. The company leverages both wholesale channels and online platforms to distribute its products, aiming to reach a wide customer base across Canada.
Products and Services
- Cannabis and Cannabis-Derivated Products:
- Hemp-Based CBD Products:
- Online and Wholesale Distribution:
- Real Estate Operations:
Specializing in the indoor cultivation and processing of high-quality cannabis, Cannara Biotech offers a variety of products derived from cannabis. These range from recreational to medicinal products, designed to meet the needs of diverse consumer segments. By controlling the cultivation environment, Cannara ensures the consistency and quality of its cannabis products.
In addition to traditional cannabis products, Cannara Biotech has expanded its portfolio to include hemp-based CBD products. These products cater to consumers looking for the therapeutic benefits of CBD without the psychoactive effects of THC. The range includes oils, edibles, and topicals, among others, catering to a growing market seeking natural wellness solutions.
To reach a broad audience, Cannara Biotech employs a dual distribution strategy. It distributes its products through wholesalers who further retail the products to the end consumers. Simultaneously, the company has embraced the digital age by retailing its products through various online merchandisers, allowing for a wider reach and convenience for customers.
Beyond its core focus on cannabis, Cannara Biotech leverages its assets and expertise in real estate. This aspect of the business supports its primary operations and provides a diversification of revenue streams. The nature of these real estate operations could range from cultivation facilities to commercial properties, underlying the company's integrated business model.
